copyright and Wegovy, two recent breakthroughs in the field of weight management, have garnered significant attention for their remarkable results. These medications, both belonging to a class called GLP-1 receptor agonists, work by stimulating the body's natural processes to reduce appetite and improve insulin sensitivity. Early clinical trials h